BUSINESS: Financial NovaBay Announces Proposed Public Offering of Common Stock and Warrants By Staff Monday, October 26, 2015 12:23 AM EMERYVILLE, Calif.—NovaBay Pharmaceuticals (NYSE MKT: NBY), based here, announced Friday that it plans to offer shares of its common stock and common stock purchase warrants in an underwritten public offering. Roth Capital Partners is acting as the sole manager for the offering.NovaBay said in a statement that it intends to use the net proceeds from this offering for working capital and general corporate purposes, including research and development, clinical trials and selling, and general and administrative expenses, including sales and marketing expenses related to its Avenova product.